BETABiohacksAI is a research tool for informational purposes only. All outputs are computational hypothesis candidates — not confirmed mechanisms, not medical advice, and not a substitute for professional medical judgment. Independent experimental validation is always required.
BiohacksAI is an evolving scientific literature platform. New compounds and evidence are indexed continuously.
B
○

Fenofibrate

An antilipemic agent which reduces both CHOLESTEROL and TRIGLYCERIDES in the blood.

297+ PubMed studies analyzed · 27 RCTs · Evidence Score: 47.7

Research Domains

Fenofibrate has been studied across 19 research domains including 🔥 Metabolic, ❤️ Cardiovascular, 🫁 Liver & Detox, 🔬 Inflammation, 🔬 Oncology. The primary research focus is 🔥 Metabolic with 59% of studies addressing this area.

Similar Compounds by Shared Targets

The following compounds share molecular targets with Fenofibrate, based on binding affinity data from BindingDB and ChEMBL. Sorted by shared target overlap.

Lynestrenol
18 shared targets
Clofibrate
12 shared targets
Toxaphene
17 shared targets
Rotenone
23 shared targets
Spironolactone
18 shared targets
2-Acetylaminofluorene
14 shared targets
Retinaldehyde
17 shared targets
Flutamide
19 shared targets
Secologanin
13 shared targets
Methylcholanthrene
13 shared targets
Loading evidence profile...

This evidence profile for Fenofibrate is generated deterministically from 297 PubMed-indexed studies. All data is corpus-verified with Merkle proofs. BiohacksAI does not provide medical advice. Always consult a healthcare professional before starting any supplement regimen.

Data source: PubMed/MEDLINE (NLM). Corpus version: current. Patent pending (EVE-PAT-2026-001). © 2026 Organiq Sweden AB.